Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences business

The goal is to create a strong partner for the booming European biotechnology and pharmaceutical industry

10-Sep-2024 - Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, intends to acquire TTP Group ("TTP"), a leading firm in consulting and engineering for the pharmaceutical and chemical industry in Europe. TTP's portfolio encompasses a wide range of engineering services, ...

Large pharma organizations to invest nearly 7% of revenue on building connected, cutting-edge lab environments by 2025

Next-gen lab environments are now critical for innovative therapies, reduced time to market, and improved approval rates, but most are still at pilot phase

08-Feb-2024 - Pharmaceutical organizations are rethinking their approach to the setup and operations of their labs, with a focus on accelerating digitalization, leveraging AI, improving processes, and building the right skills and culture for a lab transformation. The need to accelerate cycle times is driving ...

POWTECH and PARTEC 2023 – three days of processing and particle technology at the highest level

27-Sep-2023 - From 26 to 28 September 2023, POWTECH in Nuremberg will once again become the hot spot for international experts in processing technology from a wide range of user segments, especially the food and feed, chemical, and pharmaceutical industries. In four exhibition halls, 553 exhibitors from 27 ...

analytica: Significant upswing in international spin-offs

Country-specific challenges

26-Sep-2023 - The five international analytica trade fairs that make up the international cluster of the world’s leading trade fair for laboratory technology, analysis and biotechnology registered some significant increase in visitors and exhibitors this year. With the successful local spin-offs in China, ...

Drug shortages: These factors lead to supply bottlenecks in the pharmaceutical industry

Competition between generics manufacturers makes supply chains more vulnerable

31-Mar-2023 - In a recent study, Prof. Dr. Kai Hoberg (KLU), Prof. Dr. David Francas (University of Applied Sciences Worms) and Stephan Mohr (Frankfurt School of Finance and Management) looked into which conditions affect the availability of drugs in Germany. One key finding: while competition between generics ...

Researchers develop efficient process for chemical terpene synthesis

Potential applications in food, cosmetics and pharmaceutical industries

20-Feb-2023 - A team of scientists led by Professor Tanja Gulder at Leipzig University’s Institute of Organic Chemistry, together with colleagues from the University of Regensburg, has developed a simplified and efficient method for the artificial production of terpenes. Terpenes are a very extensive and ...

Green chemistry: BAM investigates pharmaceutical production without solvents and CO₂ emissions

Pharmaceutical production with mechanochemistry

28-Nov-2022 - The Bundesanstalt für Materialforschung und -prüfung (BAM) is developing a more sustainable process to produce active pharmaceutical ingredients in a major EU project: The pilot project is intended to demonstrate the advantages of mechanochemistry for more environmentally friendly and CO2-neutral ...

ACHEMA 2022 offers new impulses for the process industry

Final Report ACHEMA 2022

29-Aug-2022 - At ACHEMA 2022, the world's leading trade show for the process industry, over 2,200 exhibitors from more than 50 countries showcased the latest equipment and innovative processes for the chemical, pharmaceutical and food industries at the Frankfurt fairgrounds from 22 to 26 August. Whether it was ...

Triastek and Siemens announce strategic collaboration to accelerate digital transformation of the pharmaceutical industry

21-Mar-2022 - Triastek, Inc. and Siemens Ltd., China have signed a strategic collaboration agreement to provide digital technologies for the global pharmaceutical industry. Combining Triastek's industry-leading 3D printing and digital pharmaceutical technologies and Siemens' global leadership in automation and ...

WACKER Strengthens Biologics Business by Acquiring US-Based Plasmid DNA Manufacturer Genopis

Expansion of WACKER's portfolio as a contract manufacturer for the pharmaceutical industry

04-Feb-2021 - The Munich-based chemical company WACKER is acquiring 100 percent of the shares in pharmaceutical contract manufacturer Genopis Inc. from Helixmith Co Ltd, Seoul (South Korea) and Medivate Partners LLC, Seoul (South Korea). WACKER signed a corresponding agreement. WACKER will continue Genopis' ...